🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “Xiyuan Hospital of China Academy of Chinese Medical Sciences” Clear

  1. Remimazolam besylate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sedative

    phase 3 small molecule completed

    1 trial

  2. Riociguat

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Thromboembolic Pulmonary Hypertension

    phase 3 small molecule active

    1 trial

  3. Romiplostim

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia

    phase 3 small molecule completed

    1 trial

  4. Roux-en-Y anastomosis

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Cancer

    phase 3 other active

    1 trial

  5. SARS-CoV-2 Vaccine (Vero Cell), Inactivated

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    phase 3 mab completed

    1 trial

  6. Sacubitril-Valsartan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    STEMI

    phase 3 small molecule active

    1 trial

  7. Saline (0.9%, sterile, for infusion)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pneumocystis Jiroveci Pneumonia

    phase 3 small molecule active

    1 trial

  8. Sirolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 3 small molecule active

    1 trial

  9. Somatostatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gallbladder Neoplasms

    phase 3 small molecule completed

    1 trial

  10. Sorafenib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 3 small molecule active

    2 trials

  11. Standard First-Line Therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unresectable Colorectal Cancer

    phase 3 small molecule active

    1 trial

  12. Start antiplatelet monotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intracerebral Hemorrhage

    phase 3 small molecule completed

    1 trial

  13. Steroid nasal spray

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation-Induced Mucositis

    phase 3 small molecule active

    1 trial

  14. Subxiphoid uniportal VATS

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mediastinal Neoplasms

    phase 3 other active

    1 trial

  15. Subxiphoid uniportal VATS

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Neoplasms

    phase 3 other completed

    1 trial

  16. Supportive care+Prednisone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Minimal Change Disease

    phase 3 small molecule active

    1 trial

  17. Suzhou Sceneray® DBS System

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Opiate Addiction

    phase 3 other active

    1 trial

  18. Systematic oral health education

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Malignant Tumor of Head and/or Neck

    phase 3 other completed

    1 trial

  19. TCM

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  20. TPO

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    phase 3 small molecule active

    1 trial

  21. Tacrolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Transplantation

    phase 3 small molecule active

    1 trial

  22. Tacrolimus capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  23. Tacrolimus capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 3 small molecule completed

    1 trial

  24. Tamoxifen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer Female

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources